News
Mefloquine shortage
Shortage of 250mg mefloquine (Lariam) antimalarial tablets in the United Kingdom (UK) until the end of March 2026
Avloclor (chloroquine tablets) discontinued and Malarivon (chloroquine syrup) out of stock
Updated information for health professionals on the supply of chloroquine for malaria chemoprophylaxis
Falsified rabies vaccine: India
Falsified rabies vaccine is circulating through unauthorised sources in India
Yellow fever vaccine: supply update
Temporary disruption in supply of yellow fever vaccine (Stamaril) in the UK
Falsified antibiotics reported in WHO African Region
Falsified HEALMOXY (Amoxicillin) identified in Cameroon and Central African Republic
Falsified rabies vaccine: Zimbabwe
Falsified rabies vaccine is circulating through unauthorised sources in Zimbabwe
Rabipur Rabies vaccine product alert for health professionals
Reports of rubber particles after reconstitution- recommendations to minimise the risk of particles
Rabies vaccine shortage: advice for health professionals
Important advice on rabies vaccine shortage for health professionals
Rabies risk worldwide: practical advice for travellers during rabies vaccine shortages
An important reminder of practical aspects of rabies prevention for travellers
Outbreaks
Contaminated medicine in India
On 13 October 2025, the World Health Organization (WHO) published a Medical Product Alert about oral cold medicine in India contaminated with diethylene glycol (toxic to humans) linked to clusters of acute illness and deaths of children in India. These medicines are COLDRIF, Respifresh TR and ReLife, manufactured by Sresan Pharmaceutical, Rednex Pharmaceuticals and Shape Pharma. These contaminated oral liquid medicines named in this alert are unsafe, pose a significant risk and can cause severe, potentially life-threatening illness. Their use, especially in children, may result in serious injury or death. Please see WHO Medical Product Alert N°5/2025: Substandard (contaminated) oral liquid medicines for further details.
